 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
WHO, US Regulator Reach Deal On Anti-AIDS Drugs
Geneva (AFP) Aug 15, 2005 The UN health agency said Monday that it had reached an agreement with the United States that should expand the number of drugs available for use in HIV/AIDS treatment programmes in poor countries. The US Food and Drug Administration (FDA) and the World Health Organisation have agreed to share confidential testing data on anti-AIDS drugs destined for global aid projects, said Hans Hogerzeil, director of medicines, policy and standards at the WHO. "The WHO is extremely pleased with the agreement and decision that has been reached. We are very eager to cooperate with the FDA," Hogerzeil told AFP. "This makes it easier for us to extend our list," he added. The Geneva-based WHO's current "pre-qualification" scheme is the cornerstone of attempts to supply more affordable life-saving drugs to tackle HIV/AIDS in developing countries where they are most needed by governments and aid agencies. The scheme, a supplementary evaluation for generic and brand-name drugs use, was approved by WHO member states last year. But US authorities had been reticent about the scheme amid fears that it could shortcut stricter national regulatory approval. WHO pre-qualification does not replace national regulatory approval. However, the single endorsement by the global health agency effectively allows an anti-AIDS drug to be used in several developing countries. Hogerzeil said the deal should also allow the FDA to bolster supplies for its own fast track approval scheme for medicines that can be used in President George W. Bush's 15-billion-dollar AIDS fund. Fast-tracked FDA drugs can only be used outside the United States. Some developing countries -- including Ethiopia, Kenya and Tanzania -- had been reluctant to accept the medicines without the WHO's seal of approval, Hogerzeil said. The streamlined WHO system was introduced following controversy over attempts by poor countries and aid agencies to seek cheaper anti-retroviral drugs to treat millions of HIV/AIDS patients. The WHO admitted earlier this year that it was unlikely to meet its target of treating three million poor people with anti-AIDS drugs by the end of 2005. About one million people in developing and transitional countries were receiving anti-retroviral therapy (ART), compared with 400,000 in December 2003 when the "Three by Five" initiative was launched. Community Email This Article Comment On This Article Related Links SpaceDaily Search SpaceDaily Subscribe To SpaceDaily Express Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola
Less Threatening Bird Flu
Washington (UPI) Jan 11, 2006Talk about good news and bad news: While more cases of avian flu are identified in both birds and humans in Turkey, the first possible signs emerged that the virus itself might not be as lethal as feared. |
|
|
| The content herein, unless otherwise known to be public domain, are Copyright 1995-2006 - SpaceDaily.AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA PortalReports are copyright European Space Agency. All NASA sourced material is public domain. Additionalcopyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement |
